Sonographic features of triple-negative and non-triple-negative breast cancer

Journal of Ultrasound in Medicine

Volumn 31, Issue 10, 2012, Pages 1531-1541

  Wojcinski, Sebastian ^a   Soliman, Amr A ^a,b   Schmidt, Julia ^a   Makowski, Lars ^c   Degenhardt, Friedrich ^a   Hillemanns, Peter ^c  

^a FRANZISKUS HOSPITAL   (Germany)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Basal like breast cancer; Breast Imaging Reporting and Data System; Breast sonography; Sonographic morphologic correlation; Triple negative breast cancer

Indexed keywords

CLASSIFICATION (OF INFORMATION); DISEASES; PATHOLOGY; TUMORS; ULTRASONIC IMAGING; ULTRASONOGRAPHY;

BASAL-LIKE BREAST CANCERS; BREAST IMAGING REPORTING AND DATA SYSTEMS; BREAST SONOGRAPHY; SONOGRAPHIC-MORPHOLOGIC CORRELATIONS; TRIPLE-NEGATIVE BREAST CANCERS;

MEDICAL IMAGING;

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST TUMOR; EARLY DIAGNOSIS; ECHOGRAPHY; ECHOMAMMOGRAPHY; FEMALE; GERMANY; HUMAN; INCIDENCE; METABOLISM; MIDDLE AGED; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GERMANY; HUMANS; INCIDENCE; MIDDLE AGED; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, MAMMARY;

EID: 84867210009     PISSN: 02784297     EISSN: 15509613     Source Type: Journal    
DOI: 10.7863/jum.2012.31.10.1531     Document Type: Article

References (38)

1. Yang WT, Dryden M, Broglio K, et al. Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women. Breast Cancer Res Treat 2008; 111:405-410.
2. Anders C, Carey LA. Understanding and treating triple-negative breast cancer. Oncology (Williston Park) 2008; 22: 1233-1239.
3. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006; 295: 2492-2502.
4. Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 2007; 13: 4429-4434.
5. Herschkowitz JI, Simin K, Weigman VJ, et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 2007; 8:R76.
6. Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits ofhumanbreast tumours. Nature 2000; 406:747-752.
7. SørlieT, PerouCM, TibshiraniR, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98: 10869-10874.
8. Bertucci F, Finetti P, Cervera N, et al. How basal are triple-negative breast cancers? Int J Cancer 2008; 123:236-240.
9. Carey L, Winer E, Viale G, Cameron D, Gianni L. Triple-negative breast cancer: disease entity or title of convenience? Nat Rev Clin Oncol 2010; 7:683-692.
10. Ishihara A, Tsuda H, Kitagawa K, Yoneda M, Shiraishi T. Morphological characteristics of basal-like subtype of breast carcinoma with special reference to cytopathological features. Breast Cancer 2009; 16:179-185.
11. AndersCK, CareyLA. Biology, metastaticpatterns, andtreatmentofpatients with triple-negative breast cancer. Clin Breast Cancer 2009; 9:S73-S81.
12. Zonderland HM, Coerkamp EG, Hermans J, van de Vijver MJ, van Voorthuisen AE. Diagnosis of breast cancer: contribution of US as an adjunct to mammography. Radiology 1999; 213:413-422.
13. Wild JJ, Neal D. Use of high-frequency ultrasonic waves for detecting changes of texture in living tissue. Lancet 1951; 1:655-657.
14. Wild JJ, Reid JH. Echographic visualization of the living intact human breast. Cancer Res 1954; 14:227-282.
15. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 1995; 196:123-134.
16. Sadigh G, Carlos RC, Neal CH, Dwamena BA. Ultrasonographic differentiation of malignant from benign breast lesions: a meta-analytic comparison of elasticity and BIRADS scoring. Breast Cancer Res Treat 2012; 133:23-35.
17. Kaplan SS. Clinical utility of bilateral whole-breastUSin the evaluation of women with dense breast tissue. Radiology 2001; 221:641-649.
18. Kolb TM, Lichy J, Newhouse JH. Occult cancer in women with dense breasts: detection with screening US-diagnostic yield and tumor characteristics. Radiology 1998; 207:191-199.
19. Mendelson EB, Baum JK, Berg WA, et al. BI-RADS: ultrasound. (1st ed.) In: D'Orsi CJ, Mendelson EB, Ikeda DM, et al. Breast Imaging Reporting and Data System: ACR BI-RADS-Breast Imaging Atlas. Reston, VA: American College of Radiology; 2002.
20. Stavros AT. Breast Ultrasound. Philadelphia, PA: Lippincott Williams & Wilkins; 2004.
21. German Federal Association of Fund Doctors. Ultrasound regulations [in German]. Kassenaerztliche Bundesvereinigung website. http://www.kbv.de/ rechtsquellen/2488.html. Accessed January 26, 2012.
22. German Society for Ultrasound in Medicine Committee on Breast Ultrasound. Mehrstufenkonzept mammasonographie. Deutsche Gesellschaft für Ultraschall in der Medizin website. http://www.degum.de/Mehrstufenkonzept-Mammasonogra.634. 0.html. Accessed January 26, 2012.
23. MadjarH, OhlingerR, MundingerA, et al. [BI-RADS-analogueDEGUM criteria for findings in breast ultrasound: consensus of the DEGUM Committee on Breast Ultrasound [in German]. Ultraschall Med 2006; 27:374-379.
24. Turner N, Tutt A, Ashworth A. Hallmarks of "BRCAness" in sporadic cancers. Nat Rev Cancer 2004; 4:814-819.
25. DahabrehIJ, LinardouH, SiannisF, FountzilasG, MurrayS. Trastuzumab in the adjuvant treatment of early-stage breast cancer: a systematic review and meta-analysis of randomized controlled trials. Oncologist 2008; 13:620-630.
26. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365: 1687-1717.
27. Comen EA, Robson M. Poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer. Cancer J 2010; 16:48-52.
28. Carey LA, Dees EC, Sawyer L, et al. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 2007; 13: 2329-2334.
29. Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. JClin Oncol 2008; 26: 1275-1281.
30. von Minckwitz G, Kümmel S, Vogel P, et al. Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study. J Natl Cancer Inst 2008; 100:552-662.
31. Dogan BE, Gonzalez-Angulo AM, Gilcrease M, Dryden MJ, Yang WT. Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI. AJR Am J Roentgenol 2010; 194: 1160-1166.
32. Ko ES, Lee BH, Kim HA, Noh WC, Kim MS, Lee SA. Triple-negative breast cancer: correlation between imaging and pathological findings. Eur Radiol 2010; 20: 1111-1117.
33. Kojima Y, TsunodaH. Mammographyand ultrasound featuresof triplenegative breast cancer. Breast Cancer 2011; 18:146-151.
34. Uematsu T, Kasami M, Yuen S. Triple-negative breast cancer: correlation between MR imaging and pathologic findings. Radiology 2009; 250:638-647.
35. Elkabets M, Gifford AM, Scheel C, et al. Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. J Clin Invest 2011; 121:784-799.
36. Thike AA, Cheok PY, Jara-Lazaro AR, Tan B, Tan P, Tan PH. Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer. Mod Pathol 2010; 23:123-133.
37. Hammond ME, Hayes DF, Wolff AC, Mangu PB, Temin S. American Society of Clinical Oncology/College of American Pathologists' guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Oncol Pract 2010; 6:195-197.
38. MaibencoDC, Weiss LK, Pawlish KS, Severson RK. Axillary lymph node metastases associated with small invasive breast carcinomas. Cancer 1999; 85: 1530-1536.